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ABSTRACT
Enzymatic ethanol assays are widely used to determine blood alcohol content for individuals
admitted to a hospital. In some instances, this hospital data is later used as evidence in a court
of law, most commonly in DUI cases. As the enzymatic assay targets, but does not
exclusively measure ethanol, it is theoretically possible that interference could occur and
produce a falsely elevated result, leading to wrongful convictions or other consequences. This
project examined the potential of clinically relevant levels of one potential interferant,
lactate and the hepatic enzyme lactate dehydrogenase (LDH) to cause significant and falsely
elevated results. Threshold levels of lactate/LDH required and the magnitude of the false
positive observed were investigated. False positives were investigated in systems containing
no ethanol as well as systems containing high, medium, and low levels of ethanol. These
objectives were accomplished by adding varying amounts of lactate, LDH, and ethanol to a
simulated hospital assay on a UV-Vis spectrophotometer. The data from this experiment may
be applied by forensic toxicologists and pathologists in the interpretation of hospital
enzymatic alcohol assay results.
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CHAPTER I
Introduction
Alcohol is a very widely used drug and is therefore present in many clinical and
forensic toxicology cases. Quantitation of alcohol levels in patients may affect the clinical
treatment they receive as well as any legal consequences associated with the incident that led
to their hospitalization. Alcohol analysis and interpretation of its behavioral consequences as
well as consideration of the role of the drug in postmortem cases also forms a large part of the
forensic toxicologist’s workload (Powers & Dean, 2014; Rao, 2012).
Gas chromatography–mass spectrometry (GCMS) or gas chromatography flame
ionization detection (GC-FID) is the most accurate and reliable method of determining blood
alcohol concentration (BAC) in forensic laboratories. It is, however, expensive,
time-consuming, and requires technical proficiency (Powers & Dean, 2014; Rao, 2012).
Therefore, BAC determination in a clinical setting is usually accomplished via an alcohol
dehydrogenase-based enzymatic ethanol assay, which makes use of the reaction between
alcohol and alcohol dehydrogenase (ADH). This reaction has a cofactor, NAD+, which in the
process is reduced to NADH. The level of alcohol in the sample is proportional to the rate at
which NADH is produced. NADH absorbs light at 340 nm, (NAD+ does not) and as such,
ultraviolet-visible (UV-Vis) spectroscopy can be used to determine the amount of alcohol
present in the sample. This indirect approach can be a concern due to the potential for a
competing reaction between lactate and lactate dehydrogenase (LDH) that also produces
NADH from NAD+. Therefore, it is theoretically possible that the presence of lactate and
LDH in the serum could give false positive or falsely elevated ethanol concentrations
(Powers & Dean, 2009). It is essential that toxicologists understand the levels of lactate and
LDH required to have a measurable effect on the assay and the degree to which their presence
in serum can change the results, in order to effectively interpret the results of such an assay.
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The interference in question has been noticed anecdotally and several studies have
been conducted (Badcock & O’Reilly, 1992; Thompson, Malhotra, Schammel, Blackwell,
Ward, & Dasgupta, 1994), but only one published study has tested the in vitro effect on the
assay by spiking serum with lactate and lactate dehydrogenase (Nine, Moraca, Virji, & Rao,
1995). The study used a wide variety in the amounts of lactate and LDH incorporated in the
assay, including concentrations far above those reasonably observable in antemortem
specimens. Since that study over 20 years ago, the interference of lactate/LDH has been
tentatively accepted by the scientific community. However, there is still some contention over
its existence, prevalence, and severity; as evidenced by recent articles and court cases
contesting its relevance (Powers & Dean, 2009; Nacca, Hodgman, Lao, Elkins, & Holland,
2017). It is problematic that almost every mention of this phenomenon refers back to a single,
somewhat limited study in 1995 that failed to adequately resolve the issue (Nine et al., 1995).
Forensically, this research has multiple implications. The presence and level of
alcohol in a victim or perpetrator's system can have an influence on their behavior and frame
of mind. As a result, the amount of alcohol in a person’s blood can serve as a significant
piece of evidence in many cases. From a sentencing standpoint, the level of legal
consequences assigned to an individual can also be dependent on the blood alcohol
concentration (Powers & Dean, 2014).
With these factors in mind, it is imperative that the test used to measure ethanol levels is
reliable and accurate, and that any potential interferences or confounding factors be
recognized and considered. If there is a possibility that the enzymatic assays used widely
throughout hospitals can be inaccurate under certain conditions, it is important that the users
and interpreters of those assays know that an interference can occur, and the conditions under
which such interferences could have affected an assay.
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This project had three aims: to successfully simulate and “scale up” a clinical enzyme
assay normally performed on an automatic analyzer for use with a benchtop UV-Visible
spectrophotomer, to determine the effect of lactate/lactate dehydrogenase (LDH) added to the
assay with no ethanol present, and finally to determine the effect of lactate/LDH added to an
assay with varying amounts of ethanol present. This study was limited to amounts of LDH
and lactate corresponding to physiologically reasonable levels, both in terms of normal levels,
and reasonable elevations that might be encountered in cases of trauma, hypoxia or disease.

9

Literature Review
Background
Alcohol is a legal and commonly encountered social drug worldwide. Due to its
prevalence in American society, numerous laws and restrictions exist to govern its usage
(Powers & Dean, 2014). Therefore, analysis and interpretation of an individual’s blood
alcohol content forms a large part of forensic toxicology casework.
An individual’s blood alcohol content (BAC) may be forensically significant in a
number of ways. The treatment of an individual when they arrive at an emergency room may
be impacted by an underlying BAC (Hubler, Sullivan, & Erickson, 1998; Gharapetian,
Holmes, Urquhart, & Rosenburg, 2008). If this treatment is adversely affected by inaccurate
test results, medical malpractice suits could ensue. The BAC results of an individual could
also come into play as evidence during a trial. For example, the intoxication of a suspect or
victim will often be relevant in the course of reconstructing a crime scene or verifying
witness statements. At other times intoxication is the main focus of legal action, such as in
cases of social host liability (Justice Education Society and Centre for Education, Law, &
Society at SFU, 2017), sexual consent, or most commonly, drunk driving.
Alcohol intoxication clearly plays a significant role in legal cases and forensic science.
Therefore, it is imperative that tests used to measure it are reliable. As a consequence,
forensic laboratories typically use headspace gas chromatography (GC) with mass
spectrometry (GCMS) or flame ionization detectors (GC-FID) to accurately and reliably
measure BAC (Powers & Dean, 2014). In cases were samples are not submitted to a forensic
laboratory, an individual’s medical records can also be introduced into legal proceedings,
making hospital data potentially relevant as evidence in forensic cases. The use of headspace
GC in a clinical setting would be impractical because of its high cost in time, money, and
technician hours (Rao, 2014). Instead, hospitals routinely use alcohol dehydrogenase (ADH)
based enzymatic ethanol assays to determine BAC.
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The alcohol enzymatic assay is based on the rate of metabolism of ethanol present in a
sample as catalyzed by ADH. This reaction has a cofactor (NAD+) which is reduced to
NADH in the process. The test usually consists of introducing a sample in a reaction mixture
containing ADH, NAD+, and a buffer (Cheng & Christian, 1978). The rate of appearance of
NADH can then be measured at its λmax of 340 nm. Since the initial rate of NADH formation
is proportional to the amount of ethanol present, this parameter can be used to calculate the
concentration of ethanol in the sample. The sample usually used in this test is serum (to
reduce interference from the color of whole blood on absorbance), and the serum
concentration is then adjusted using an average ratio to obtain the BAC for whole blood
(Powers & Dean, 2014). In contrast to headspace GC, the enzymatic assay is quick and
cost-effective (Rao, 2014) and yields quantitatively accurate results a high percentage of the
time albeit with a larger underlying procedural uncertainty (Powers & Dean, 2014). From a
forensic standpoint, this accuracy is beneficial because hospital data can act as evidence at a
later time.
The use of an enzymatic-based alcohol quantification for legal purposes is a concern
because it is theoretically possible for the assay to produce positive results from an
unintentional co-reaction. The assay indirectly measures the concentration of ethanol via its
reaction cofactor; therefore a competing reaction that has the same cofactor could also
produce NADH and influence the results (Powers & Dean, 2014). The classic example of a
potentially competing reaction is the metabolism of lactate by lactate dehydrogenase, or LDH
(Figure 1). This reaction has the potential to cause an interference in the assay by producing
NADH independent of ethanol content in the sample (Nine, Moraca, Virji, & Rao, 1995). The
presence of NADH generated by the action of LDH on lactate in the test could result in a
falsely elevated ethanol concentration result.
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In order for lactate/LDH
interference to occur, certain
conditions must be in place.
LDH is an enzyme normally
found primarily in the liver,
with relatively insignificant
concentrations routinely
detectable in the blood. High
concentrations would only be

Figure 1: Mechanism of alcohol metabolism (top) & possible
interfering reaction (bottom)[Powers & Dean, 2009; updated 2018]

expected in the blood of individuals with liver damage as a result of chronic disease or
trauma (Powers & Dean, 2009). In addition to LDH, the substrate (lactate) must also be
present. Lactate is normally seen at low levels in the blood as a metabolic intermediate
(Powers & Dean, 2009) but can be found in higher concentrations if the individual has
experienced respiratory or metabolic acidosis (Rao, 2014). Treatment with Lactated Ringer’s
solution has also been suggested as a source of lactate (Rao, 2014). In the presence of high
levels of both LDH and lactate, it is theoretically possible to produce NADH independently
of ethanol and obtain a falsely elevated result. This interference could thus influence the
results without disrupting any of the usual calibrations and quality control measures used to
monitor the assay’s function (Rao, 2014). This interference is thought to be relatively rare
(Powers & Dean, 2014) and has been sparingly studied in recent years.
Previous Research
The first recognition of the potential for this interference was in 1992, during a study of
SIDS (Badcock & O'Reilly, 1992). Researchers noted that postmortem plasma for the infant
subjects occasionally tested positive for ethanol when measured with enzymatic assays, but
the samples produced negative results when measured with GC. To determine the origin of
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the interference, they ran an assay in the absence of ADH and obtained the same positive
results. Surmising that lactate/LDH might be the cause, they added lactate and observed an
increase in the rate of A340 absorbance increase; then they added an LDH inhibitor and noted
a rate decrease. These results led the investigators to conclude that high levels of lactate/LDH
in the serum samples could be the cause. In retrospect, this finding was consistent with later
published literature, which indicated that concentrations of LDH/lactate increase postmortem
(Rao, 2014). This study convincingly established the existence of interference in postmortem
cases and provided compelling evidence that high lactate and LDH were responsible.
A few years later, two additional anecdotal cases of living patients were reported, also
showing similarly elevated levels of lactate and LDH (Thompson et al., 1994). The
researchers noted that this phenomenon could appear in both ante- and post-mortem cases.
Further confirmation of the enzymatic basis of the observation was demonstrated by running
the tests again after ultrafiltration of the sera, removing protein and hence LDH from the
sample. Notably, this step eliminated interference from the assay, suggesting that LDH is
somehow involved in the falsely heightened “alcohol” readings, and the interference was not
a function of lactate alone. Their study provided more evidence to support the suspected
lactate/LDH interference. Thompson et al. (1994) also added varying amounts of lactate and
LDH to serum samples to observe the response. This aspect of their study provided more
examples of interference but was not systematic enough to define the levels of lactate and
LDH in which it might occur.
The most widely cited article on this topic was conducted by Nine et al. (1995), entitled
“Serum-Ethanol Determination: Comparison of Lactate and Lactate Dehydrogenase
Interference in Three Enzymatic Assays”. The study was conducted in two parts. The first
part determined the postmortem lactate and LDH levels of 17 autopsy subjects, finding them
to be elevated in many cases. The researchers also tested the subjects’ ethanol content via
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three enzymatic assays (Syva, Roche, and Abbott), with headspace GC-FID used as a
reference method. In some of these cases, the elevated lactate/LDH was correlated with false
positive ethanol results. This part of the study provided data documenting post-mortem levels
of lactate and LDH, albeit mostly for individuals with some underlying disease state.
In the second part of the study, researchers spiked serum from a healthy volunteer
with lactate and LDH in various amounts and noted that high levels also caused elevated
ethanol readings. This process, however, affected some enzymatic tests more than others. The
in vitro testing used levels of lactate and LDH far beyond those commonly encountered in
clinical antemortem samples, leading to criticism and dismissal of the study by some
toxicologists (Winek & Wahba, 1996). This article successfully showed that the interference
can happen, including in postmortem cases. This article and associated research had the
potential to settle the question of the existence of the interference in antemortem cases using
its in vitro data but did not successfully do so. Reasons for their failure could be the use of
extremely high levels of lactate/LDH, publication in the same article as postmortem studies,
or ineffective presentation of data. Regardless, their study did not resolve the issue, as
indicated by the conflicting publications since that time.
Despite some criticism, the potential interference of lactate/LDH with the ADH assay
has been tentatively accepted in the years since 1995 and is mentioned in toxicology
textbooks (Powers & Dean, 2014; Rao, 2012) and courses as a possible but rare occurrence.
The issue was again brought to the attention of researchers in 2008, with a letter to the editor
communicating 3 more cases of apparently falsely elevated ethanol in a 2-month span
(Gharapetian, Holmes, Urquhart, & Rosenburg, 2008). This publication noted that the
interference is a problem because it influenced one of the individual’s medical care. Another
concern raised by the authors was that the levels of lactate and LDH present were not high
enough to be a concern according to the threshold values communicated by the enzyme assay
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manufacturer. Unfortunately, it is not possible to effectively compare the levels of LDH
found in their patients (4871, 8075, and 10,147 U/L) with Nine’s study, because their data did
not include examples for levels of LDH between 3748 and 10, 331 U/L (Nine, Moraca, Virji,
& Rao, 1995).
Soon afterward, the validity of a hospital enzyme assay was questioned in a legal case
arising from a DUI charge. In 2009, Powers & Dean published on a court case handled by the
Connecticut Department of Public Safety (Powers & Dean, 2009). In the case, a driver had
collided with a tree and in the subsequent trial, the hospital records were submitted as
evidence of drunk driving. The hospital test resulted in a BAC of 0.17 g/dL, more than twice
the legal limit of 0.08 g/dL. The defense challenged the accuracy of the assay on the basis of
interference by elevated lactate/LDH. Although the individual’s lactate and LDH values were
not measured during hospitalization, the authors were able to approximate the amounts of
lactate/LDH by using other clinical markers such as the anion gap and levels of hepatic
enzyme present in the serum. Using this data, it was concluded that for this particular case the
results of the assay were not falsely elevated. However, the authors noted that the interference
could possibly be legitimate if the amounts of lactate and LDH were higher. Their article
demonstrated that the interference is a relevant concern in the prosecution of modern cases,
and further that such cases could be evaluated by examination of clinical parameters.
In 2011, an evaluation of the lactate/LDH interference was conducted by the College
of American Pathologists as a part of their proficiency testing program (Frederick & King,
2012). Fifty labs used their normal enzyme assay to test samples containing lactate and LDH
in clinically possible concentrations and reported the resulting ethanol concentrations. There
was a significant amount of variation depending on the type and brand of instrumentation
used; false ethanol readings ranged from 0.004 to 0.106 g/dL. The authors emphasized that
this interference is still a problem 20 years after its recognition and offered suggestions for
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the testing procedure to eliminate interference. However, the likelihood of these changes
being made in clinical settings is low because of their additional effort and cost, and the
perceived infrequency of the lactate/LDH based interference. The article showed the
prevalence of enzymatic assays and the range of false positives that can occur.
In contrast to most other publications that accepted the potential of interference by
lactate/LDH in enzymatic-based alcohol assays, the most recent publication on this topic
appeared to dismiss its relevance in a clinical setting. In 2017, a study was published which
examined the lactate/LDH levels of live patients presenting to a single hospital over the
course of 8 months (Nacca, Hodgman, Lao, Elkins, & Holland, 2017). If the patients had
elevated levels of lactate/LDH, their BAC was tested by both enzymatic assay and GC-FID.
Results showed only 4 of the 37 patients had a measurable BAC by enzyme assay; all 4 also
had similar BACs when confirmed by GC-FID. This led the researchers to state that their data
does not support the validity of an interference in live patients.
While this study (as the first conducted on live patients) reflected an important step in
the investigation of this issue, the limitations in the experimental design somewhat
compromise the overall utility of the research, and limit its applicability to the larger question.
The authors themselves recognize that a sample size of 37 is quite small and that their sample
included no trauma victims, only victims of disease (Nacca et al., 2017). The lack of trauma
victims is a concern because two of the conditions leading to elevated lactate and LDH,
hepatic trauma and acidosis, are commonly encountered in trauma victims. It is possible that
trauma victims represent a significant number of cases in which this interference occurs.
Considering the relative rarity of this phenomenon, it also seems likely that their study was
not large enough to catch the occurrences known to occur as indicated in previous
publications (Thompson et al., 1994; Frederick & King, 2012; Gharapetian et al., 2008).
Another concern is that their study only used a Roche enzyme assay, but claim that their
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result “likely applies to the other available products” (Nacca et al., 2017, p.3). Although all
enzyme assays operate on similar principles, it is clear from the literature that there is quite a
bit of variation from one assay to another (Nine et al., 1995; Frederick & King, 2012). Thus
the claim that their results are generalizable is misleading. In fact, the entire study carries risk
of misinterpretation. In reality, neither their data nor that which came before provides enough
information to confidently disregard or confirm the interference.
Current Research
It is troubling that researchers in this area have only one reference table of
interferences and the lactate/LDH levels required to cause them: the data provided by Nine et
al., over 20 years ago. Nine’s study made for an excellent beginning, but it is somewhat
problematic that the work was not followed by a more definitive study. Scientists working in
the field today need an accurate, modern, and complete reference for values of lactate, LDH,
and the effect they may have on the ethanol reading from a particular assay. Essentially,
thresholds for concentrations of lactate and LDH that can produce a positive result by
themselves in an ethanol assay would be of value in most clinical settings, facilitating
interpretation of data.
Several issues raised in the Nine study were addressed in this project. First, the levels
of lactate and LDH were restricted to clinically reasonable concentrations. Within these
parameters, more data points were tested. In particular, the gap between 3748 and 10,331 U/L
of LDH, unaddressed by Nine, was investigated. During the course of testing the magnitude
of false positives was also determined. In addition to the potential to produce false positives
independently, the combinations of lactate and LDH were studied to determine the potential
additive effect on existing alcohol levels. This has contributed to a better understanding of
situations in which an endogenous level of ethanol is present, but the test results show a
higher level of ethanol due to the presence of lactate/LDH.
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The aims of this study were to provide a more complete understanding of the levels of
lactate and LDH necessary to cause a false positive, the magnitude of the false positive
produced, and the effects of high lactate and LDH on a system with endogenous ethanol. The
first step was to scale up an enzyme assay for use on a benchtop UV-VIS. The second phase
validated, updated, and expanded the data provided by Nine while remaining within
concentrations expected in a live patient. The third provided data on the interaction between
lactate/LDH along with existing levels of ethanol in that sample. Finally, select samples from
Parts II and III were validated using a human serum matrix. Together, these tables of data
will be useful as forensic toxicologists and pathologists examine medical records in the
course of an investigation. By enriching the information available, the data obtained in this
study will allow scientists to more accurately interpret the results of a hospital enzyme assay.
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CHAPTER II: MATERIALS & METHODS
Methods
Part I: Standard Curve
The alcohol dehydrogenase enzyme assay was adapted from hospital procedures for use
on a Shimadzu UV-1700 absorbance ultraviolet-visible spectrophotometer (UV-Vis). The
procedure from SYNCHRON® Systems was used as a template (Beckman Coulter Inc, 2010)
to determine initial concentrations and ratios of the assay components. The Beckman Coulter
assay is a “continuous flow” assay, which required conversion to a defined volume, single
cell assay for use in this project. The assay was then performed on a set of ethanol standard
solutions and an ethanol test solution of unknown concentration to determine its accuracy and
precision. Adjustments to the assay’s reagent concentrations, ratios, and procedures were
made. These adjustments included the type and volume of cuvette, instrumental parameters,
ratio of assay components to sample, duration of data collection, sample mixing, sample and
reagent temperature control, and various measuring devices. These experiments resulted in
the following method, used to collect the standard curve data as well as the experimental data
in the following sections.
1.1 Solution preparation
All solutions were kept on ice while in use and refrigerated otherwise. Solid enzyme
and cofactor powders were kept in the freezer when not in use.
1.1.1

Ethanol standards
140 proof ethanol (Sigma-Aldrich) was serially diluted
with distilled water to produce ethanol standards of the
concentrations listed in Table 1. 20 mL of each standard
was prepared. Class A glass pipets and volumetric flasks
were used. These concentrations were verified using gas
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TABLE 1:
Concentration of
ethanol standards
Sample Ethanol
No.
(mg/dL)
1
0
2
31.25
3
62.5
4
125
5
250
6
500

chromatography with flame ionization detection (GC-FID). The ethanol test
solution for determining accuracy/percent error was also prepared using this
method; its final concentration was found to be 86 mg/dL, again using
GC-FID.
1.1.2

TRIS buffer
~24.2 g Trizma (Sigma-Aldrich) was dissolved in ~900 mL distilled water to
produce a 200 mM buffer solution. Concentrated hydrochloric acid was
added dropwise to pH ~7.6, then distilled water was added up to 1.0 L.

1.1.3

Nicotinamide adenine dinucleotide (NAD) Stock Solution
~0.12 g of NAD (Sigma-Aldrich) was dissolved in 10 mL TRIS buffer.
Solution was prepared fresh each day of use.

1.1.4

Alcohol dehydrogenase (ADH) Stock Solution
~0.001 g of ADH from yeast (Sigma-Aldrich) was dissolved in 10 mL TRIS
buffer. Solution was prepared fresh each day of use.

1.1.5

Enzyme mix
500 µL of ADH and 10 mL of NAD stock solutions were combined and
diluted 1:5 with buffer to obtain an enzyme/cofactor mix, hereafter referred
to as the ‘reaction reagent’ or ‘enzyme mix’. The concentrations of these
constituents in the final assay incubation were ~2.5 mM NAD and ~200 U/L
ADH.

1.2 Assay Procedures
A triplicate 6-point standard curve was generated for each day of data collection and
used to calibrate the results from that day. An additional test solution of ethanol was
also analyzed and used to determine the accuracy of the standard curve.
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1.2.1

Sample preparation
For each standard, micropipettes were used to deliver 700 µL enzyme mix,
200 µL TRIS buffer, and 100 µL of the ethanol standard into a plastic test
tube. All samples had a final incubation volume of 1.0 mL. The contents
were mixed by gently ‘flicking’ the tube three times, then incubated in a
room-temperature water bath for 10 seconds. The sample was then
transferred to a polystyrene disposable cuvette (pathlength=1 cm) and
inserted into the UV-Vis. Data collection was then initiated on the
instrument.

1.2.2

Instrument settings
The UV-1700 was operated using Shimadzu UVProbe software in Kinetics
mode, to collect the rate of absorbance change at a single wavelength over
time. The instrument method collected absorbance at λ=340 nm over a period
of 30 seconds, initiated just after insertion of the cuvette. The average rate of
absorbance in units of mAbs/min was calculated by the UVProbe software.

1.2.3

Data interpretation
The absorbance rates for each standard were plotted on a substrate-velocity
curve and Lineweaver-Burke plot. Lineweaver-Burke plots were produced
for each set of standards by plotting the inverse of the concentrations versus
the inverse of their average absorbance rates The accuracy and precision of
the standards was assessed by calculating percent standard deviation of the
triplicate values (acceptance criteria: <20%), trendline fit for the
Lineweaver-Burke plot (acceptance criteria: R2>0.97), and percent error
(acceptance criteria: <10%) of the result obtained after running the ethanol
positive control solution.
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Part II: The Effect of Lactate and LDH on an Assay without Ethanol
In the second phase of the project, the effects of lactate and LDH were studied on the
assay containing the reaction reagent but no ethanol.
2.1 Solution preparation
All solutions were kept on ice while in use and refrigerated otherwise. Solid enzyme
and cofactor powders were kept in the freezer when not in use. Tris buffer, reaction
reagent, and ethanol standards were prepared in the same manner as the previous
section.
2.1.1

Lactate solutions
The stock solution (Sigma, ~11,775 mmol/L) was diluted
with distilled water serially to produce solutions of the
concentrations listed in Table 2. Class A glass pipets and
volumetric flasks were used.

2.1.2

LDH Stock solutions

TABLE 2
Concentration of
lactate samples
Sample Lactate
No.
(mmol/L)
1
0
2
1
3
5
4
10
5
25
6
50

LDH stock solution (Sigma-Aldrich, from rabbit muscle; ~550 U/mg; 10
mg/2 mL) was serially diluted with distilled water to produce solutions of the
concentrations listed in Table 3. Class A glass pipets and volumetric flasks
were used.
2.1.3

Lactate & LDH solution concentrations
Representative concentrations ranging from normal blood
reference levels (lactate 0.5-2.2 mmol/L; LDH 122-225
U/L, Nacca 2017) to the upper limits of clinical
concentrations were used (as shown in Tables 2-3).

2.2 Calibration
The assay was calibrated as per section 1.2 above.
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TABLE 3
Concentration of
LDH samples
Sample
LDH
No.
(U/L)
1
0
2
200
3
1000
4
2000
5
4000
6
6000
7
8000
8
10 000

2.3 Sample matrices
Using the procedures as noted above (sections 1.12 – 1.23), lactate and LDH were
analyzed on the assay in various combinations, resulting in a series of data matrices
(see Table 4). In each matrix, the concentration of LDH was held constant while
varying the concentration of lactate. Incubation samples included 700 µL reaction
reagent, 100 µL lactate, 100 µL LDH, and 100 µL buffer. Each sample was run in
triplicate.
2.3.1

Control samples
A matrix of samples with lactate but no LDH was performed to verify that no
reaction occurs between lactate and the reaction reagent in the absence of
ethanol and LDH. Each sample contained 700 µL of reaction reagent, 200 µL
of buffer, and 100 µL of the lactate solution (concentrations listed in Table 2).
To verify that no reaction occurs when LDH is added in absence of lactate, a
control sample with LDH and reaction reagent, but no ethanol or lactate, was
included in each sample matrix.

2.1 Data interpretation
Using the standard curve for

TABLE 4: Example of a sample matrix for Part II
Reaction reagent

100 µL LDH

100 µL lactate

TRIS buffer

the same day, the results

700 µL

8000 U/L

--

200 µL

were translated into

700 µL

8000 U/L

1.0 mM

100 µL

perceived ethanol (mg/dL)

700 µL

8000 U/L

5.0 mM

100 µL

700 µL

8000 U/L

10.0 mM

100 µL

700 µL

8000 U/L

25.0 mM

100 µL

700 µL

8000 U/L

50.0 mM

100 µL

results. For each matrix, the
results were plotted with
perceived BAC in terms of
lactate concentration.
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Part III: The Effect of Lactate and LDH on an Assay with Ethanol Standard Solutions
Part III was similar to Part II, but in these cases the incubation contained ethanol as well
as various combinations of lactate and LDH. High (125 mg/dL), medium (62.5 mg/dL) and
low (31.25 mg/dL) concentrations of ethanol were added to the matrices from Part II.3.1
Solution preparation
Same as Part II.
3.2 Calibration
Same as Part II.
3.3 Sample matrices
Similar procedures to Part II were used, except for the addition of ethanol to each
sample. Each matrix (see Table 5) had a constant concentration of LDH and ethanol
while varying the concentration of lactate. Incubation samples included 700 µL
reaction reagent, 100 µL lactate, 100 µL LDH, and 100 µL ethanol.
TABLE 5: Example of a sample matrix for Part III
Reaction reagent

100 µL LDH

100 µL lactate

TRIS buffer

100 µL ethanol

700 µL

8000 U/L

--

100 µL

31.25 mg/dL

700 µL

8000 U/L

1.0 mM

--

31.25 mg/dL

700 µL

8000 U/L

5.0 mM

--

31.25 mg/dL

700 µL

8000 U/L

10.0 mM

--

31.25 mg/dL

700 µL

8000 U/L

25.0 mM

--

31.25 mg/dL

700 µL

8000 U/L

50.0 mM

--

31.25 mg/dL

3.3.1 Control samples
Control samples of lactate and ethanol in the absence of LDH as well as LDH and
ethanol in the absence of lactate were conducted as in Part II. In addition, control
samples of ethanol with lactate & LDH were performed in absence of ADH to
evaluate the effect of ethanol on the reaction between LDH & lactate.
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3.4 Data interpretation
Same as Part II.
Part IV: Verification of Results using a Human Serum Matrix
Human serum was used to prepare test solutions and validate the results obtained in
buffer for Parts II and III. Similar procedures were followed, except solutions of ethanol,
lactate, and LDH were prepared in human serum (Sigma) instead of distilled water.
4.1 Sample matrices
Selected combinations of LDH and lactate were tested with final concentrations of
200, 6000, and 10,000 U/L LDH, and 1, 10, and 50 mM lactate. As above, each
matrix held the concentration of LDH constant while varying the amount of lactate.
Each sample consisted of 700 µL enzyme mix, 100 µL LDH, 100 µL lactate, and
100µL buffer. Each combination was analyzed in triplicate.
4.2 Data interpretation
The results from the human serum trials were compared with the results from Parts II
and III to verify that the results were reasonably similar to serum samples.
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Materials
All reagents (Table 6) were procured from Sigma Aldrich, except for those already in
stock. Results were gathered from a UV-1700 spectrophotometer (Shimadzu). Digital data
was collected using a Dell Latitude E6520 laptop computer, attached to the UV-1700 by a
USB-to-RS232 cable. Data reduction was performed by UVProbe 2.60 software (Shimadzu).
Standard laboratory glassware and equipment was procured from Fischer Scientific.

TABLE 6: Materials List
Reagents

Equipment

Ethanol, 140 proof
Alcohol dehydrogenase (ADH) from yeast
Nicotinamide adenine dinucleotide (NAD)
TRIS buffer
Lactate
Lactate dehydrogenase (LDH)
Human serum
Hydrochloric acid

UV-1700 (Shimadzu)
Reusable cuvettes
Reusable test tubes
Computer
Adapter cable
UV Probe 2.6 Software
Lab glassware
Ice bucket
Micropipettes & tips
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3DUW,6WDQGDUG&XUYH
(WKDQROVWDQGDUGVXVHGWRFDOLEUDWHWKHH[SHULPHQWDOUHVXOWVHDFKGD\ZHUHUXQLQ
WULSOLFDWHDQGHYDOXDWHGIRUWKHLUDFFXUDF\DQGSUHFLVLRQDVGHVFULEHGLQVHFWLRQDERYH 
7KHUHZHUHQRLQVWDQFHVRIVWDQGDUGFXUYHUHMHFWLRQEDVHGRQIDLOXUHWRPHHWDFFHSWDQFH

)LJXUH5HSUHVHQWDWLYHH[DPSOHRIVXEVWUDWHYHORFLW\SORWIRUHWKDQROVWDQGDUGV
)LJXUH5HSUHVHQWDWLYHH[DPSOHRIVXEVWUDWHYHORFLW\SORWIRUHWKDQROVWDQGDUGV

FULWHULD 6HFWLRQ 7KHVWDQGDUGVZHUHSORWWHGRSSRVLWHWKHLUDYHUDJHUDWHVRIDEVRUEDQFH
FKDQJHWRREWDLQDVXEVWUDWHYHORFLW\SORWVHH)LJXUHIRUDUHSUHVHQWDWLYHH[DPSOH7KH
VWDQGDUGFXUYHZDVHYDOXDWHGIRUSUHFLVLRQZLWKWKHXVHRISHUFHQWVWDQGDUGGHYLDWLRQRIWKH
WULSOLFDWHFDOLEUDWRUV7KHSHUFHQWVWDQGDUGGHYLDWLRQVKDGDQDYHUDJHYDOXHRIDQGD
UDQJHRI DFFHSWDQFHFULWHULD 
/LQHZHDYHU%XUNHSORWVZHUHDOVRSURGXFHGIRUHDFKVHWRIVWDQGDUGV VHH)LJXUHIRUD
UHSUHVHQWDWLYHH[DPSOH 7KHVWDQGDUGVZHUHHYDOXDWHGIRUDFFXUDF\XVLQJWUHQGOLQHILWWKH
EHVWILWWLQJVWUDLJKWOLQHZDVXVHGDVWKHVWDQGDUGFXUYHIRUHDFKGD\RIGDWDFROOHFWLRQ7KH5
YDOXHVZHUHW\SLFDOO\JUHDWHUWKDQRQHVHWRIVWDQGDUGVKDGDORZHU5RI
DFFHSWDQFHFULWHULD5! 7KHVWDQGDUGFXUYHZDVDOVRXVHGWRFDOFXODWHSHUFHQWHUURU



IRUWKHHWKDQROFRQWUROWHVWVROXWLRQ WDUJHWYDOXHPJG/ WKHVHSHUFHQWHUURUVKDGDQ
DYHUDJHSHUFHQWHUURURIZLWKDUDQJHRIHUURU DFFHSWDQFHFULWHULD  

)LJXUH5HSUHVHQWDWLYHH[DPSOHRI/LQHZHDYHU%XUNHSORWIRUHWKDQRO
)LJXUH5HSUHVHQWDWLYHH[DPSOHRI/LQHZHDYHU%XUNHSORWIRUHWKDQRO

3DUW,,7KH(IIHFWRI/DFWDWHDQG/'+RQDQ$VVD\ZLWKRXW(WKDQRO


7KH³HWKDQRO´UHVXOWVJHQHUDWHGLQWKHDOFRKRODVVD\IRUYDU\LQJFRPELQDWLRQVRIODFWDWH

)LJXUH$SSDUHQWHWKDQROOHYHOV REVHUYHGLQDQHQ]\PDWLFDVVD\FRQWDLQLQJRQO\$'+/'+ODFWDWHDQG1$'
1RWH7KHFRQWUROVDPSOHRI]HURODFWDWHZDVXVHGDVWKHµ]HURSRLQW¶IRULWVUHVSHFWLYHPDWUL[RIGDWD 



DQG/'+LQWKHDEVHQFHRIHWKDQROLQWKHUHDFWLRQPL[DUHJLYHQLQ)LJXUH$V
K\SRWKHVL]HGQRIDOVHSRVLWLYHUHVXOWVZHUHREVHUYHGLQHLWKHUW\SHRIFRQWUROVDPSOH
FRQWDLQLQJQRODFWDWHRUQR/'+7KHHWKDQROUHVXOWVDUHFRUUHODWHGSRVLWLYHO\ZLWKHOHYDWHG
ODFWDWHDQG/'+FRQFHQWUDWLRQVZLWKYDOXHVJUHDWHUWKDQJG/RFFXUULQJDWDQGDERYH
8//'+DQGP0ODFWDWH1RVLJQLILFDQWIDOVHSRVLWLYHV !JG/ ZHUHREVHUYHG
DWSK\VLRORJLFDOO\QRUPDOOHYHOVRIODFWDWHDQG/'+ LQGLFDWHGRQ)LJXUH $WWKHKLJKHVW
OHYHOVRI/'+DQGODFWDWH 8/DQGP0UHVSHFWLYHO\ WKHDSSDUHQWHWKDQROUHVXOW
UHDFKHGJG/ 
7KHDSSDUHQWEORRGDOFRKROFRQWHQWREVHUYHGLQIDOVHSRVLWLYHVIRUWKLVHQ]\PHDVVD\FDQ
EHH[SUHVVHGLQPJG/E\WKHHTXDWLRQEHORZ (TXDWLRQ DVDIXQFWLRQRIODFWDWH P0 DQG
/'+ N8/ 7KLVHTXDWLRQZDVGHULYHGE\XVLQJWKHREVHUYHGOLQHDUUHODWLRQVKLSLQWKH

(W2+  >/'+@>/'+@±>/'+@  >ODFWDWH@ ±
(TXDWLRQ3UHGLFWLYHHTXDWLRQIRUDSSUR[LPDWHIDOVHSRVLWLYHUHVXOWZLWKNQRZQEORRG
OHYHOVRIODFWDWHDQG/'+

)LJXUH6ORSHDVDIXQFWLRQRI/'+FRQFHQWUDWLRQIRUHDFKPDWUL[RIGDWD

SHUFHLYHGHWKDQROUHVXOWVIRUHDFKOHYHORI/'+DVDIXQFWLRQRIODFWDWH7KHVORSHRIWKLVOLQH
LVGHSHQGHQWRQWKHFRQFHQWUDWLRQRI/'+WKHVORSHDQGWKH/'+FRQFHQWUDWLRQKDYHDQ
H[SRQHQWLDOUHODWLRQVKLS VHH)LJXUH 7KHOLQHDUUHODWLRQVKLSEHWZHHQWKHDSSDUHQWHWKDQRO
UHVXOWVDQGWKHH[SRQHQWLDOUHODWLRQVKLSEHWZHHQWKHVORSH/'+FRQFHQWUDWLRQZHUHFRPELQHG


WRGHULYH(TXDWLRQ,WVYDOLGLW\ZDVWHVWHGE\LQSXWWLQJWKHH[SHULPHQWDOYDOXHVRIODFWDWH
DQG/'+WHVWHGLQWKLVSURMHFWWKHQFRPSDULQJWKHUHVXOWVRIWKHHTXDWLRQZLWKWKH
H[SHULPHQWDOUHVXOWV VHH)LJXUH 7KHSUHGLFWHGYDOXHVFRUUHODWHGUHDVRQDEO\ZHOOZLWKWKH
H[SHULPHQWYDOXHVHVSHFLDOO\DWKLJKHUOHYHOVRIODFWDWH VHH7DEOH 7KLVHTXDWLRQPD\EH
XVHGWRSUHGLFWDSSUR[LPDWHIDOVHSRVLWLYHPDJQLWXGHVIRUYDOXHVRIODFWDWHDQG/'+
FRQFHQWUDWLRQVRWKHUWKDQWKRVHWHVWHGLQWKLVH[SHULPHQW+RZHYHUEHFDXVHWKLVHTXDWLRQZDV
GHULYHGEDVHGRQGDWDIURPWKHHQ]\PHDVVD\XVHGDW81+LWVQXPHULFDOUHVXOWVDUHRQO\
DSSOLFDEOHWRVDPSOHVDQDO\]HGXVLQJWKHVDPHHQ]\PHDVVD\$VLPLODUFRQFHSWXDODSSURDFK
FRXOGEHXVHGZLWKDQRWKHUDVVD\WRGHULYHDQHTXDWLRQIRUDQRWKHUV\VWHP
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3DUW,,,7KH(IIHFWRI/DFWDWHDQG/'+RQDQ$VVD\ZLWK(WKDQRO6WDQGDUG6ROXWLRQV
3HUFHLYHGHWKDQROUHVXOWVIRUV\VWHPVFRQWDLQLQJPJG/PJG/DQG
PJG/HWKDQRODUHUHSUHVHQWHGLQ)LJXUHVUHVSHFWLYHO\7KHUHVXOWVLQGLFDWHWKDWWKHWZR 

)LJXUH$SSDUHQWHWKDQROOHYHOVREVHUYHGLQDQHQ]\PDWLFDVVD\FRQWDLQLQJ$'+
/'+ODFWDWH1$'DQGPJG/HWKDQRO (UURUEDUV VWDQGDUGGHYLDWLRQV 

HQ]\PHV\VWHPV ODFWDWHDQGHWKDQRO FDQSURGXFH1$'+VLPXOWDQHRXVO\7KLVGXDOPRUH
UDSLGSURGXFWLRQRI1$'+OHDGVWRDKLJKHUDSSDUHQWHWKDQROUHVXOWWKDQH[SHFWHGIRUD
FHUWDLQOHYHORIHWKDQRODORQHLQWKHV\VWHP,QHDFKILJXUHWKHJUD\VKDGHGDUHDUHSUHVHQWV
WKHH[SHFWHGHWKDQROUHVXOWIRUWKHDPRXQWRIHWKDQRODFWXDOO\SUHVHQWLQWKHV\VWHP(OHYDWHG

)LJXUH$SSDUHQWHWKDQROOHYHOVREVHUYHGLQDQHQ]\PDWLFDVVD\FRQWDLQLQJ$'+/'+
ODFWDWH1$'DQGPJG/HWKDQRO (UURUEDUV VWDQGDUGGHYLDWLRQV 



SHUFHLYHGHWKDQROUHVXOWVZHUHREVHUYHGLQDOOWKUHHV\VWHPVDWDQGDERYH8//'+$V
LQDV\VWHPZLWKQRHWKDQROKLJKHUOHYHOVRIODFWDWHDQG/'+JHQHUDOO\OHGWRKLJKHU
µHWKDQRO¶UHVXOWV+RZHYHUDWDORZOHYHORIHWKDQRO PJG/)LJXUH WKHUHVXOWVIRU
8//'+ZHUHKLJKHUWKDQWKRVHIRUDQG8//'+7KHUHDVRQIRUWKLV
DQRPDO\LVXQNQRZQ
,WLVDOVRDSSDUHQWWKDWWKHV\VWHPZLWKDKLJKOHYHORIHWKDQRO PJG/)LJXUH 
H[KLELWHGDSURSRUWLRQDWHO\VPDOOHUVLJQDOLQFUHDVHFRPSDUHGWRWKHRWKHUWZRV\VWHPV7KH
UHVXOWVIRUWKLVV\VWHPDOVRGLVSOD\HGDOHVVOLQHDUUHVSRQVHDVWKHFRQFHQWUDWLRQRIODFWDWHZDV

)LJXUH$SSDUHQWHWKDQROOHYHOVREVHUYHGLQDQHQ]\PDWLFDVVD\FRQWDLQLQJ$'+/'+
ODFWDWH1$'DQGPJG/HWKDQRO (UURUEDUV VWDQGDUGGHYLDWLRQV 

LQFUHDVHG7KHVHUHVXOWVVHHPWRLQGLFDWHWKDWVRPHIRUPRILQWHUDFWLRQRFFXUVEHWZHHQWKH
HWKDQROUHDFWLRQDQGWKHODFWDWHUHDFWLRQZKLFKLVPRVWUHDGLO\REVHUYDEOHDWKLJKHUOHYHOVRI
HWKDQRO,IWKHWZRHQ]\PHUHDFWLRQVRFFXUUHGZLWKQRLQWHUDFWLRQLWZRXOGEHUHDVRQDEOHIRU
WKHPDJQLWXGHRIWKHLUFRPELQHGDVVD\UHVXOWWREHDSSUR[LPDWHO\HTXDOWRWKHUHVXOWVRIERWK
VHSDUDWHDVVD\UHVXOWVDGGHGWRJHWKHU:KHQWKHUHVXOWVRIWKHVHSDUDWHUHDFWLRQVZHUH
FRPSDUHGZLWKWKHFRPELQHGUHDFWLRQQRVLJQLILFDQWGLIIHUHQFHVZHUHREVHUYHGIRUWKHORZ
DQGPHGLXPOHYHOVRIHWKDQRO )LJXUHV +RZHYHUDWDKLJKOHYHORIHWKDQRO )LJXUHV
 WKHFRPELQHGUHVXOWZDVFRQVLVWHQWO\ORZHUWKDQWKHVXPRIWKHWZRVHSDUDWHUHDFWLRQV


This indicates that there may be some kind of interaction or interference between the two
reactions when they are occurring simultaneously.
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)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG
EHWZHHQVXPRIHWKDQRO$'+ EOXH ODFWDWH/'+ \HOORZ DQGDFRPELQHGV\VWHP JUHHQ 

)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG
EHWZHHQVXPRIHWKDQRO$'+ EOXH ODFWDWH/'+ \HOORZ DQGDFRPELQHGV\VWHP JUHHQ 



)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG
EHWZHHQVXPRIHWKDQRO$'+ EOXH ODFWDWH/'+ \HOORZ DQGDFRPELQHGV\VWHP JUHHQ 





)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG
EHWZHHQVXPRIHWKDQRO$'+ EOXH ODFWDWH/'+ \HOORZ DQGDFRPELQHGV\VWHP JUHHQ 



)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP6XPRIHWKDQRO$'+ EOXH DQG
ODFWDWH/'+ \HOORZ LVFRQVLVWHQWO\KLJKHUWKDQWKHFRPELQHGV\VWHP JUHHQ 



)LJXUH5HVXOWVRIVHSDUDWHUHDFWLRQVFRPSDUHGZLWKDFRPELQHGV\VWHP6XPRIHWKDQRO$'+ EOXH DQG
ODFWDWH/'+ \HOORZ LVFRQVLVWHQWO\KLJKHUWKDQWKHFRPELQHGV\VWHP JUHHQ 



To investigate whether ethanol could be directly inhibiting the LDH enzyme, low,
medium and high levels of ethanol were added to a lactate/LDH reaction containing no ADH.
Therefore, the ethanol would not be metabolized by ADH, so it could not produce NADH via
that mechanism. The only signal produced in this version of the assay would be from the
lactate/LDH reaction. When these results were compared to lactate/LDH results in the
absence of ethanol, no significant differences were observed at LDH 4000 U/L or 6000 U/L
(Figures 16-17), even with high levels of ethanol (125 mg/dL). Lower than expected results
were observed at LDH 10,000 U/L (Figure 18), which indicates that ethanol is unlikely to be
an inhibitor of LDH. If ethanol were inhibiting the LDH enzyme, a reduction of signal would
be expected at lower levels of LDH enzyme, not higher levels. Since only the high level of
LDH enzyme exhibited a reduction in signal, it is more likely that the ethanol and lactate
reactions are competing for the cofactor NAD+. This hypothesis is supported by the fact that
the results are lower than expected when there are high levels of both reactions occurring at
once, meaning that there might not be enough cofactor in the system to support both reactions.
This is also logical because the assay was optimized using the ethanol reaction by itself, not
both reactions simultaneously. This hypothesis could be tested by varying the amount of
NAD+ in the system to determine if the drop in signal still occurred at high levels of both
reactions.
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)LJXUH(IIHFWRIHWKDQRODGGHGWRODFWDWH/'+UHDFWLRQLQORZPHGLXPDQGKLJKDPRXQWVFRPSDUHGWR
ODFWDWH/'+ZLWKQRHWKDQROSUHVHQW1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG



)LJXUH(IIHFWRIHWKDQRODGGHGWRODFWDWH/'+UHDFWLRQLQORZPHGLXPDQGKLJKDPRXQWVFRPSDUHGWR
ODFWDWH/'+ZLWKQRHWKDQROSUHVHQW1RVLJQLILFDQWGLIIHUHQFHVREVHUYHG



)LJXUH(IIHFWRIHWKDQRODGGHGWRODFWDWH/'+UHDFWLRQLQORZPHGLXPDQGKLJKDPRXQWVFRPSDUHGWR
ODFWDWH/'+ZLWKQRHWKDQROSUHVHQW/RZHUUHVXOWVREVHUYHGZKHQHWKDQROLVSUHVHQW



3DUW,99HULILFDWLRQRI5HVXOWVXVLQJD+XPDQ6HUXP0DWUL[


:KHQVDPSOHVSUHSDUHGLQKXPDQVHUXPZHUHFRPSDUHGWRWKHVDPSOHVLQ3DUW,, D

ODFWDWH/'+V\VWHPZLWKQRHWKDQRO QRVLJQLILFDQWGLIIHUHQFHVZHUHREVHUYHG)LJXUH
VKRZVDFRPSDULVRQRIWKHUHVXOWVZLWKKXPDQVHUXP EOXH DQGZDWHUPDWULFHV \HOORZ ,Q
DOOEXWRQHFRPELQDWLRQRIODFWDWH/'+WKHHUURUEDUVRYHUODSLQGLFDWLQJWKDWWKHKXPDQ
VHUXPKDGVLPLODUUHVXOWVWRWKHZDWHUPDWUL[ZLWKLQWZRVWDQGDUGGHYLDWLRQV$WWKHKLJKHVW
FRPELQDWLRQRIODFWDWH P0 DQG/'+ 8/ WKHHUURUEDUVGLGQRWRYHUODSEXWWKH
SHUFHQWGLIIHUHQFHEHWZHHQWKHUHVXOWVZDVa7KHVHUHVXOWVLQGLFDWHWKDWWKHUHVSRQVH
RIDVDPSOHLQKXPDQVHUXPVXFKDVLQFOLQLFDOVDPSOHVVKRXOGKDYHUHDVRQDEO\VLPLODU
UHVXOWVDVWKHVDPSOHVWHVWHGLQ3DUW,,RIWKLVH[SHULPHQW

)LJXUH5HVXOWVIURPVDPSOHVUXQLQKXPDQVHUXPFRPSDUHGWRWKRVHLQZDWHUV\VWHPFRQWDLQLQJ$'+
1$'/'+DQGODFWDWH



:KHQVDPSOHVSUHSDUHGLQKXPDQVHUXPZHUHFRPSDUHGWRWKRVHIURP3DUW,,,PXFK

KLJKHUUHVXOWVZHUHREVHUYHGIRUWKHKXPDQVHUXPWULDOV VHH7DEOH 7KHDVVD\ZDVDOVRUXQ
ZLWKRXWWKHFRIDFWRU1$'DQGWKH$'+HQ]\PHWRGHWHUPLQHZKDWPLJKWEHFDXVLQJWKH
GLVFUHSDQF\%HFDXVHWKHUHDUHSRVLWLYHUHVXOWVIURPWKHVDPSOHVZLWKQRFRIDFWRUDGGHGWR



the assay, it is likely that the human serum matrix contains some cofactor. This could explain
the higher values observed in the human serum as compared to the water matrix. Extra
cofactor would not have affected the results in Figure 19 to the same degree, because there
was only one enzyme reaction occurring (between lactate and LDH). In the results from Part
III, the ethanol and lactate reactions are occurring simultaneously, so there may have been
some competition for the cofactor. In this case, extra cofactor in the serum could have
increased the rate of reaction by preventing competition for the cofactor.
TABLE 8: Human serum results compared with water matrix results in a system with
31.25 mg/dL ethanol and 6000 U/L LDH
Lactate
(mM)

Water Matrix
Results (mg/dL)

Human Serum
Results (mg/dL)
91.82792

Human Serum
[no NAD in assay]
(mg/dL)
18.71938

Human Serum
[no ADH in assay]
(mg/dL)
42.37956

1

22.35262

10

38.936

101.2568

25.51718

70.71358

50

115.6277

161.9857

23.66795

137.4986

Quantitative enzyme assays normally have both cofactor and enzyme available in excess
so that the rate of reaction is limited only by the amount of substrate (ethanol) introduced in
the serum sample. Since this ethanol enzyme assay was optimized and tested with ethanol
standards only, there may be plenty of cofactor for a single reaction at a time. But as has been
observed in Parts III and IV of this project, an unexpected second reaction could lead to
competitive and less predictable results. This could also be a concern with hospital enzyme
assays because they are likely developed and verified with ethanol standards as well.
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CHAPTER IV: CONCLUSIONS & FUTURE RESEARCH
Conclusions
The results of this project indicate that while interference in the ADH enzymatic
assay from a co-reaction between lactate and LDH is rarely observed, but may still be a
concern if the interference is unrecognized. The assumption that this interference may have
occurred may also undermine the appropriate use or interpretation of valid results of the
enzyme assay in either the medical community or legal forums. The data from this project
indicates that while false positives are indeed possible (reinforcing previous work in this
area), but only when lactate and LDH are both elevated significantly above normal
physiological levels. The potential for interference may be recognized by observing the anion
gap and the values of ALT/AST; if these are higher than expected, elevated lactate and LDH
(respectively) could be contributing the perceived ethanol result.
In a system with no endogenous ethanol, lactate and LDH were found to produce
significant false positives, correlating with higher levels of both. The behavior of such a
system was documented and an equation was derived to predict approximate false positive
magnitudes for combinations of lactate and LDH that were not tested.
In a system with endogenous ethanol, additive effects were observed when both the
ethanol and the lactate reactions were occurring simultaneously. This could result in the level
of ethanol being overstated based on the assay results. The additive effects were smaller in a
system with a high level of endogenous ethanol, so there may be some competition or other
interaction between the two reactions that is not fully understood at this time. Ethanol does
not appear to be a substrate (BRENDA) or inhibitor for LDH. Competition for the cofactor
NAD+ may be a potential explanation, although further research on this topic is needed.
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Future Research
Further experimentation is needed to clarify the additive effects of ethanol, lactate,
and LDH in a system with some level of endogenous ethanol. In particular, systems with high
levels of endogenous ethanol should be examined because unexpected results were observed
in the system with 125 mg/dL ethanol. Systems with 250 mg/dL ethanol or higher might
provide more insight into the behavior of a system with both reactions occurring
simultaneously, as well as the impact of ethanol on the lactate/LDH reaction. A lactate/LDH
assay could also be developed and varying amounts of ethanol could be added to determine
its influence on the lactate/LDH reaction.
Another experiment that might clarify the effects of a combination system could be
conducted by varying the amount of NAD+ present to determine if it is a limiting factor. If so,
it might be possible to reoptimize the ethanol assay with an excess of NAD+ so that the
reaction speed is completely controlled by the amount of substrate introduced in the sample.
In addition to these in vitro studies, it would also be useful to conduct survey studies to
determine some larger questions about the occurrence of this interference in a clinical setting.
For example, how often does elevated lactate and LDH occur in trauma victims as well as
illness victims? Historically, have ALT/AST hepatic enzyme values been shown to accurately
predict the level of LDH present in the blood? It would be useful to understand how prevalent
elevated levels of lactate and LDH are clinically, and whether the traditional methods of
estimating their concentrations are reliable. These studies, along with the work conducted on
this project, will continue to deepen the understanding of these false positives and provide
valuable information on how to interpret these results in a legal setting.
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